CNIPA.AI

Company patentsCompare

HEAD TO HEAD

Bank of ChinaEli LillyTesla

Technology portfolios compared in the same window and counting units. Scale is compared only within the same field or subclass.

Same window · published 2025-01-01 — 2025-12-31Some name or date coverage is incomplete; affected counts are lower bounds

This is a structural comparison of collected portfolios. The same requested window does not establish equal entity scope, covered months or industry; no competitive ranking is inferred.

Applicant-name coverage differs. The counts below cover only the listed names and do not represent complete company portfolios.

Bank of China: Applicant names included in these statistics — BANK OF CHINA CO LTD · BANK OF CHINA LTDReviewed names not covered — BANK OF CHINA LIMITED · 中国银行股份有限公司

Eli Lilly: Applicant names included in these statistics — ELI LILLY AND CO · ELI LILLY AND COMPANY USA · LILLY CO ELIReviewed names not covered — ELI LILLY AND COMPANY

Tesla: Applicant names included in these statistics — TESLA INC · TESLA MOTORS INCReviewed names not covered — TESLA MOTORS, INC. · TESLA, INC.

Bank of China

Publications
138
Invention share
98%
Concentration
0.75
Green technology
—

Eli Lilly

Publications
1,602
Invention share
45%
Concentration
0.73
Green technology
—

Tesla

Publications
609
Invention share
91%
Concentration
0.29
Green technology
—
0.01

Bank of China × Eli Lilly

0.40

Bank of China × Tesla

0.01

Eli Lilly × Tesla

Cosine similarity of application counts across 35 fields. 1 is identical, 0 is no overlap.

01Technology field mirror

The 12 fields with the largest combined share. Share shows structure; count shows scale.

Technology field mirror
Technology fieldBank of China / Eli Lilly / Tesla
Computer technology
74.6%
0.6%
24.4%
Pharmaceuticals
0%
68.5%
0%
IT methods for management
42%
0.2%
0.7%
Biotechnology
0%
39.9%
0%
Electrical machinery, apparatus, energy
0%
0%
33.6%
Transport
0%
0%
31.6%
Organic fine chemistry
0%
25.8%
0%
Medical technology
0%
17.6%
0.2%
Digital communication
13.8%
0.1%
2.4%
Audio-visual technology
3.6%
0.1%
4.5%
Semiconductors
0%
0%
6.2%
Mechanical elements
0.7%
0%
5.2%

Inspect one technology field

Inspect collected applications, portfolio share and supporting publications within one field. A technology overlap does not establish that companies in different industries are direct competitors.

Tesla

Collected applications
27
Share of collected applications with IPC
4.5%

Coverage is incomplete; counts and shares describe only the collected subset.

View Tesla publications in this field

One application may belong to multiple fields, so shares can sum to more than 100%. Drill-down lists publications; an application publication and its grant may appear separately.

02Same problem: shared IPC subclasses

The 10 subclasses in every company's top 60 with the most combined applications. Scale is compared within a subclass, never across different business scopes.

G06FData processing
Bank of China83
Eli Lilly2
Tesla85
G06NComputing models, AI
Bank of China18
Eli Lilly3
Tesla66
G06VImage and video recognition
Bank of China18
Eli Lilly2
Tesla48
G06TImage processing
Bank of China7
Eli Lilly5
Tesla21

03Where each one leans

Observed emphasis within each company’s collected top-60 IPC subclasses. A dash for another company means outside its top-60 list, not zero applications or a market gap. Incomplete coverage can also change the ordering.

Bank of China

  • G06FData processing
    Bank of China
    83
    Eli Lilly
    2
    Tesla
    85
  • G06QBusiness data processing
    Bank of China
    58
    Eli Lilly
    3
    Tesla
    —
  • H04LDigital transmission
    Bank of China
    19
    Eli Lilly
    —
    Tesla
    13
  • G06VImage and video recognition
    Bank of China
    18
    Eli Lilly
    2
    Tesla
    48
  • G06NComputing models, AI
    Bank of China
    18
    Eli Lilly
    3
    Tesla
    66
  • G06TImage processing
    Bank of China
    7
    Eli Lilly
    5
    Tesla
    21

Eli Lilly

  • A61K
    Bank of China
    —
    Eli Lilly
    926
    Tesla
    —
  • A61P
    Bank of China
    —
    Eli Lilly
    766
    Tesla
    —
  • C07K
    Bank of China
    —
    Eli Lilly
    454
    Tesla
    —
  • C07DHeterocyclic compounds
    Bank of China
    —
    Eli Lilly
    300
    Tesla
    —
  • A61M
    Bank of China
    —
    Eli Lilly
    196
    Tesla
    —
  • C12NMicroorganisms, enzymes
    Bank of China
    —
    Eli Lilly
    153
    Tesla
    —

Tesla

  • H01MBatteries, electrochemical cells
    Bank of China
    —
    Eli Lilly
    —
    Tesla
    115
  • B60LElectric vehicle propulsion
    Bank of China
    —
    Eli Lilly
    —
    Tesla
    36
  • B62DBodies, chassis
    Bank of China
    —
    Eli Lilly
    —
    Tesla
    36
  • B60WVehicle sub-unit control
    Bank of China
    —
    Eli Lilly
    —
    Tesla
    35
  • B60RVehicle electrics, fittings
    Bank of China
    —
    Eli Lilly
    —
    Tesla
    30
  • H10W
    Bank of China
    —
    Eli Lilly
    —
    Tesla
    27

04Publication rhythm

Bank of ChinaEli LillyTeslaPublications per period
Publications per period
PeriodBank of ChinaEli LillyTesla
2025-01≥19 (partial coverage)≥118 (partial coverage)≥57 (partial coverage)
2025-02≥65 (partial coverage)≥121 (partial coverage)≥37 (partial coverage)
2025-03≥51 (partial coverage)≥158 (partial coverage)≥27 (partial coverage)
2025-04Not collected≥110 (partial coverage)≥43 (partial coverage)
2025-05Not collected≥134 (partial coverage)≥60 (partial coverage)
2025-06Not collected≥140 (partial coverage)≥58 (partial coverage)
2025-07Not collected≥138 (partial coverage)≥52 (partial coverage)
2025-08Not collected≥134 (partial coverage)≥56 (partial coverage)
2025-09≥1 (partial coverage)≥132 (partial coverage)≥52 (partial coverage)
2025-10Not collected≥155 (partial coverage)≥56 (partial coverage)
2025-11Not collected≥140 (partial coverage)≥54 (partial coverage)
2025-12≥2 (partial coverage)≥122 (partial coverage)≥57 (partial coverage)

Empty dashed outlines mark uncollected periods. Hatched bars and ≥ counts mark partial coverage.

Publication timing follows examination and publication cycles, not R&D intensity.

What makes it comparableThe same publication window and counting units. Companies with different windows are not put in one comparison.

What is not comparableGroup totals. Business and entity scopes differ; compare scale within a field or subclass.

Not a rankingSimilarity and shares describe structure, not patent value, quality or technical leadership.